DGAP-Adhoc: UMS AG continues expansion: Acquisition of Mobile Biopsy, Inc.

 | Quelle: EQS Group AG EQS Group AG 

UMS United Medical Systems International AG  / Key word(s): Acquisition

15.04.2011 20:00

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---------------------------------------------------------------------------

UMS AG continues expansion: Acquisition of Mobile Biopsy, Inc.  

Hamburg, April 15, 2011 - UMS United Medical Systems International AG
(UMS/ISIN DE0005493654) has acquired Mobile Biopsy, Inc., Statesville,
North-Carolina (USA), via its U.S. subsidiary. Mobile Biopsy operates seven
mobile stereotactic biopsy units serving customers from Florida to
Pennsylvania. The acquisition will increase the Company's revenues in the
Gynecology segment by around USD 2.3 million per year. In 2010, revenues in
this segment totaled USD 13.2 million.

This acquisition, which took effect April 15, 2011, enables UMS to continue
its strategy of regional expansion and will strongly improve its presence
in the southeastern United States. The parties have agreed not to disclose
the purchase price.

Contact:

Wiebke Budwasch, Tel: +49 40 50 01 77-0, Fax: +49 40 50 01 77-77, E-mail:
investor@umsag.com






Kontakt:

Wiebke Budwasch, Tel: (040) 50 01 77-00, Fax: (040) 50 01 77-77, E-Mail:
investor@umsag.com















15.04.2011 DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases. 
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      UMS United Medical Systems International AG
              Borsteler Chaussee 53
              22453 Hamburg
              Deutschland
Phone:        +49 (0)40 - 500 177 - 00
Fax:          +49 (0)40 - 500 177 - 77
E-mail:       investor@umsag.com
Internet:     www.umsag.com
ISIN:         DE0005493654
WKN:          549365
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Düsseldorf, Hamburg, München, Stuttgart
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------
GlobeNewswire